The front-end experience is intuitive and seamless. Researchers easily perform searches to find the studies they are interested in. After requesting access to the data, an approval sequence kicks off to ensure proper usage of the data (hypothesis-driven research, affiliated researchers are employed by labs and universities, etc.). Data is analyzed in a custom research environment built by Insight and housed directly on the Vivli platform. Researchers then submit and request the extraction of their results from the platform, using it to publish a paper in a medical journal.
Built-in reporting and an optimized admin portal have led to drastic time savings for Vivli’s admins — no spreadsheets, disparate email chains or other channels. In fact, Vivli has reported time savings of 35 hours per month on reporting processes. Data on Vivli has been used to design clinical trial protocols and guidelines, and predict therapeutic outcomes and adverse events.
Groundbreaking work on the horizon
Vivli is rapidly building momentum on the platform’s success with new projects. The COVID-19 Therapeutics Accelerator, for example, is making COVID-19–related clinical trial data more discoverable to improve COVID response.
Another initiative called the Antimicrobial Resistance (AMR) Register is empowering biopharmaceutical companies to share susceptibility data on infection-causing pathogens. According to Vivli, “This marks a critical step in combating the growing global health threat of antimicrobial resistance…researchers will be able to use the AMR Register to translate masses of antimicrobial resistance surveillance data into meaningful action that saves lives and preserves antibiotics for future generations.”
Insight continues to serve as Vivli’s production and software development arm, partnering closely on upgrades that will drive even more efficiencies and eliminate manual and redundant processes on the back end.
Vivli Executive Director Rebecca Li, PhD, is excited for what the future holds. “The biggest outcome for us has been the result of all the research,” she says. “We’ve had more than 100 scientific publications that have come from the work Vivli has done with researchers.”
“We have made a significant impact on the state of scientific knowledge and clinical therapies. Partnering with Insight has really been key to our overall business success.”